|
![]() Alder Biopharmaceuticals Inc. Completes Series C Financing—Delphi Ventures and TPG Biotech led the $40 million round. Also participating were existing investors Sevin Rosen Funds, Ventures West, H.I.G. Ventures, and WRF Capital. Alder plans to use the financing to advance its lead programs through human clinical trials and to continue to advance its proprietary Mab Xpress yeast antibody production technology. Read the release |
![]() |
||


